Antidepressant ‘shrooms: rebranding psilocybin as medication [W[R]C]
Sixtine Fleury is a second-year graduate student in the Nautiyal Lab at Dartmouth College (NH, USA). At this year’s meeting of the Society for Neuroscience (SfN; 12–16 November; San Diego, CA, USA), she presented a poster on altered consciousness and the role of the non-hallucinatory serotonin 1B receptor in psilocybin’s therapeutic effects.
We had the chance to chat to her about her poster and her experience at SfN.
Sponsored by The BlogDealer – Health, Fitness and Fat Reduction.
Listen to “Antidepressant ‘shrooms: rebranding psilocybin as medication [W[R]C]” on Spreaker.
